Moderna seeks FDA approval of Omicron-targeted COVID shot for kids from six to 17

Moderna seeks FDA nod for Omicron-targeted COVID shot for adolescents, younger kids Moderna Inc said on Friday it has requested U.S. authorization for use of its Omicron-targeting COVID vaccine in adolescents and children. Reuters Reuters

...

The company is seeking emergency use authorization of its updated vaccine in two age groups - adolescents aged 12 to 17 years and children aged six to 11.

The application for the bivalent vaccine for children between the ages of six months and under six years is expected to be completed later this year, the company said in a tweet.

...